Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Trevi Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −1 vs. Q4 2022
- Shares held
- 43.5M
- +276.6K (+0.6%) vs. Q4 2022
- Total value
- $80.4M
- −$2.94M (−3.5%) vs. Q4 2022
- New holders
- 3
- 11 more added
- Sold out
- 4
- 8 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 265 | $490 | 0.00% | +4+1.5% | Added |
| Morgan Stanley | 384 | $710 | 0.00% | −55−12.5% | Reduced |
| UBS Group AG | 7,580 | $14.0K | 0.00% | +4,489+145.2% | Added |
| LPL Financial LLC | 10,000 | $18.5K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 11,474 | $21.2K | 0.00% | +11,474 | New |
| Charles Schwab Investment Management Inc | 12,557 | $23.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 12,928 | $23.9K | 0.00% | −15,725−54.9% | Reduced |
| Bank of New York Mellon Corp | 14,098 | $26.1K | 0.00% | 00.0% | Unchanged |
| Bailard, Inc. | 21,200 | $39.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 27,666 | $51.2K | 0.00% | +27,666 | New |
| United Bank | 28,450 | $52.6K | 0.01% | 00.0% | Unchanged |
| Atom Investors LP | 34,471 | $63.8K | 0.03% | +9,095+35.8% | Added |
| Millennium Management LLC | 59,628 | $110.0K | 0.00% | −97,996−62.2% | Reduced |
| Northern Trust Corp | 64,183 | $118.7K | 0.00% | +10,068+18.6% | Added |
| Citadel Advisors LLC | 71,655 | $132.6K | 0.00% | +27,439+62.1% | Added |
| BlackRock Inc. | 82,245 | $152.2K | 0.00% | +1,474+1.8% | Added |
| Trust Co of Toledo NA | 83,000 | $153.6K | 0.03% | +83,000 | New |
| Innovis Asset Management LLC | 87,369 | $161.6K | 0.07% | −84−0.1% | Reduced |
| J. Goldman & Co LP | 89,188 | $165.0K | 0.01% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 93,500 | $173.0K | 0.06% | 00.0% | Unchanged |
| State Street Corp | 99,542 | $184.2K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 188,400 | $348.5K | 0.01% | −20,000−9.6% | Reduced |
| Tejara Capital Ltd | 190,218 | $351.9K | 0.18% | +40,260+26.8% | Added |
| Renaissance Technologies LLC | 237,400 | $439.0K | 0.00% | −80,600−25.3% | Reduced |
| Geode Capital Management, LLC | 248,293 | $459.3K | 0.00% | +36,746+17.4% | Added |
| Opaleye Management Inc. | 835,800 | $1.55M | 0.46% | +350,800+72.3% | Added |
| Silverarc Capital Management, LLC | 885,924 | $1.64M | 0.74% | +118,293+15.4% | Added |
| Vanguard Group Inc | 1,499,751 | $2.77M | 0.00% | +60,158+4.2% | Added |
| MAI Capital Management | 1,600,415 | $2.96M | 0.05% | −120,261−7.0% | Reduced |
| VR Adviser, LLC | 3,050,022 | $5.64M | 1.10% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 4,400,000 | $8.14M | 0.04% | 00.0% | Unchanged |
| Rubric Capital Management LP | 5,684,420 | $10.5M | 0.42% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 5,696,515 | $10.5M | 1.81% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 6,663,590 | $12.3M | 0.89% | 00.0% | Unchanged |
| NEA Management Company, LLC | 11,370,376 | $21.0M | 1.45% | −2,7980.0% | Reduced |
| Bank of Montreal | 0 | $0 | 0.00% | −152,300−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,995−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −92−100.0% | Sold out |